Following research by Hemispherx Biopharma that st
Post# of 61
Posted On: 02/10/2014 1:26:19 PM
Following research by Hemispherx Biopharma that stated the importance in using interferons to treat influenza, interferon patents are now in focus by major pharmaceutical companies. AMARQ holds five of these types of patents, which could prove to be a very valuable asset to the company when bigger firms are seeking similar patents. $ARMAQ
(0)
(0)AINOS Inc. (AIMDD) Stock Research Links
Scroll down for more posts ▼